Email: [email protected]
Pricing Disclaimer: Pricing, availability, program terms, refund terms, shipping, HSA/FSA eligibility, and support features are brand-stated and subject to change
an affiliate of Bausch Health US: Grant/Research Support, Jasmohan Bajaj: Bausch: Grant/Research Support, Sequana: Grant/Research Support, Cosmo: Grant/Research Support, Grifols: Grant/Research Support, Craig McClain: Novo Nordisk: Grant/Research Support, Intercept Pharmaceuticals: Grant/Research Support, Altimmune: Grant/Research Support, Target Pharma Solutions: Grant/Research Support, NIH: Grant/Research Support, VAMC: Grant/Research Support, Ayse Aytaman: Nothing to Disclose, Tamar Taddei: Nothing to Disclose 2138 COMPARATIVE ANALYSIS ON THE HEALTHCARE DISPARITIES AND IN-PATIENT MORTALITY OF HEPATORENAL SYNDROME AMONG DIFFERENT LIVER CIRRHOSIS ETIOLOGIES: INSIGHTS FROM THE NATIONAL INPATIENT SAMPLE 2020 DATABASE Raghav Bassi 1 Zubair Bodla 2 Mohammad AbuAssi 2 Harsimran Kalsi 2 Kobina Essilfie-Quaye 2 Yaseen Perbtani 2 Tony Brar 2 , 1 University of Central Florida College of Medicine, 2 University of Central Florida Background: The three most common causes of cirrhosis in the developed world are alcoholic liver disease, metabolic dysfunction-associated steatotic liver disease (MASLD), and hepatitis C virus (HCV)
Thats because the skin can stretch during weight gain and doesnt always bounce back fully as elasticity decreases
The increased risk of bleeding due to drug-drug interactions in patients administered direct oral anticoagulants
